Danielle Bargo is a Health Economist known for utilizing real world data to generate evidence that informs health policy decisions. With over 10 years of experience in the Pharmaceutical Industry, Danielle currently serves as the Director of Value Strategy & Evidence at AstraZeneca. Previously, Danielle held leadership positions at Flatiron Health, Eisai, Pfizer, and others, contributing significantly to health technology assessments and global real-world evidence initiatives. Danielle earned a BA from Butler University and an MSc from the London School of Economics, and is currently pursuing a Doctorate in Health Policy at Johns Hopkins Bloomberg School of Public Health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices